Eurazeo acquired a $200 million majority stake in Cranial Technologies, a Tempe, Ariz.-based company treating infant plagiocephaly, per Fortune’s Term Sheet.
Eurazeo Invests $200M in Cranial Technolgies
Related Posts
$9.3M Grant to Create Center for Cancer Control in Persistent Poverty Areas through the UAB
s one of only five universities selected, UAB joins the NIH’s first major program to address how structural and institutional factors of persistent poverty relate to cancer.
Kenshō Health Raises $3.5M Seed Round
This brings Kenshō's funding total to nearly $5.5 million.
Season Health Raises $34M in Series A
Andreessen Horowitz led the round.
White Oak Healthcare Finance Provides Financing to HighFive Healthcare
HighFive specifically works with oral surgeons and endodontist under a single portfolio company.